Herpes Simplex Type 2
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Participants With Recurrent Genital Herpes (NCT01687595) | Agenus Inc. | 2012-10-29 |
Track Herpes Simplex Type 2 automatically
Every clearance here is in the API, with alerts when new ones post.